Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 60

1.

Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.

Hultquist JF, Harris RS.

Future Virol. 2009 Nov 1;4(6):605.

PMID:
20174454
[PubMed]
Free PMC Article
2.

Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.

Albin JS, Harris RS.

Expert Rev Mol Med. 2010 Jan 22;12:e4. doi: 10.1017/S1462399409001343. Review.

PMID:
20096141
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Desimmie BA, Delviks-Frankenberrry KA, Burdick RC, Qi D, Izumi T, Pathak VK.

J Mol Biol. 2014 Mar 20;426(6):1220-45. doi: 10.1016/j.jmb.2013.10.033. Epub 2013 Nov 2. Review.

PMID:
24189052
[PubMed - indexed for MEDLINE]
4.

A novel HIV-1 restriction factor that is biologically distinct from APOBEC3 cytidine deaminases in a human T cell line CEM.NKR.

Zhou T, Han Y, Dang Y, Wang X, Zheng YH.

Retrovirology. 2009 Apr 3;6:31. doi: 10.1186/1742-4690-6-31.

PMID:
19344514
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.

Russell RA, Pathak VK.

J Virol. 2007 Aug;81(15):8201-10. Epub 2007 May 23.

PMID:
17522216
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3).

Pillai SK, Wong JK, Barbour JD.

Retrovirology. 2008 Mar 13;5:26. doi: 10.1186/1742-4690-5-26.

PMID:
18339206
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.

He Z, Zhang W, Chen G, Xu R, Yu XF.

J Mol Biol. 2008 Sep 12;381(4):1000-11. doi: 10.1016/j.jmb.2008.06.061. Epub 2008 Jun 28.

PMID:
18619467
[PubMed - indexed for MEDLINE]
8.

Different interaction between HIV-1 Vif and its cellular target proteins APOBEC3G/APOBEC3F.

Nagao T, Yamashita T, Miyake A, Uchiyama T, Nomaguchi M, Adachi A.

J Med Invest. 2010 Feb;57(1-2):89-94.

PMID:
20299747
[PubMed - indexed for MEDLINE]
Free Article
9.

HIV-1 Vif, APOBEC, and intrinsic immunity.

Goila-Gaur R, Strebel K.

Retrovirology. 2008 Jun 24;5:51. doi: 10.1186/1742-4690-5-51. Review.

PMID:
18577210
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

[Mechanisms for inhibition of retrovirus replication by APOBEC3 family].

Iwatani Y.

Uirusu. 2011 Jun;61(1):67-72. Review. Japanese.

PMID:
21972557
[PubMed - indexed for MEDLINE]
Free Article
11.

Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.

Mehle A, Strack B, Ancuta P, Zhang C, McPike M, Gabuzda D.

J Biol Chem. 2004 Feb 27;279(9):7792-8. Epub 2003 Dec 13.

PMID:
14672928
[PubMed - indexed for MEDLINE]
Free Article
12.

Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.

Russell RA, Smith J, Barr R, Bhattacharyya D, Pathak VK.

J Virol. 2009 Feb;83(4):1992-2003. doi: 10.1128/JVI.01621-08. Epub 2008 Nov 26.

PMID:
19036809
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[Research methods of anti-HIV-1 inhibitors targeting at Vif-APOBEC3G axis].

Qiao X, Zhang W, Li Z, Zeng Y.

Zhongguo Zhong Yao Za Zhi. 2011 Mar;36(6):806-9. Review. Chinese.

PMID:
21710755
[PubMed - indexed for MEDLINE]
14.

Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism.

Marin M, Golem S, Rose KM, Kozak SL, Kabat D.

J Virol. 2008 Jan;82(2):987-98. Epub 2007 Oct 31.

PMID:
17977970
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins.

Jónsson SR, Haché G, Stenglein MD, Fahrenkrug SC, Andrésdóttir V, Harris RS.

Nucleic Acids Res. 2006;34(19):5683-94. Epub 2006 Oct 11.

PMID:
17038330
[PubMed - indexed for MEDLINE]
Free PMC Article
16.
17.

Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.

Wichroski MJ, Robb GB, Rana TM.

PLoS Pathog. 2006 May;2(5):e41. Epub 2006 May 12.

PMID:
16699599
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases.

Dutko JA, Schäfer A, Kenny AE, Cullen BR, Curcio MJ.

Curr Biol. 2005 Apr 12;15(7):661-6.

PMID:
15823539
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.

Xu H, Svarovskaia ES, Barr R, Zhang Y, Khan MA, Strebel K, Pathak VK.

Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5652-7. Epub 2004 Mar 30.

PMID:
15054139
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk